SCHEMBL3893018

SCHEMBL3893018

COC(=O)c1c(Br)cncc1Nc1ccccc1F.O=C(O)c1c(Br)cncc1Nc1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCL8 P10145 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ MAPT P10636 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ P4HTM Q9NXG6 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ AURKA O14965 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36
▸ CDC7 O00311 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3896811 0.95 HTT (0.42) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL3887038 0.91 CXCL8 (0.47) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL3884629 0.80 CDC7 (0.41) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL14392325 0.77 CXCL8 (0.46) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL3895292 0.76 HTT (0.43) KDM4EMAPTHTTNPC1RAB9A
SCHEMBL31613387 0.74 KDM4E (0.45) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL26985120 0.74 KDM4E (0.45) CXCL8KDM4EMAPTHTTNPC1
SCHEMBL20187445 0.74 ATM (0.43) KDM4EHTTRAB9AMAPK1ALDH1A1
SCHEMBL3732479 0.73 KDM4E (0.50) KDM4EMAPTHTTRAB9AALDH1A1
SCHEMBL31394030 0.72 ATM (0.50) KDM4EHTTRAB9AMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8076486-B2 Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors MERCK SERONO S.A. (CH) 2011-12-13 — — US disclosed
EP-2013180-A1 NOVEL HETEROARYL-SUBSTITUTED ARYLAMINOPYRIDINE DERIVATIVES AS MEK INHIBITORS Laboratoires Serono SA (CH) 2009-01-14 — — EP disclosed
WO-2007123936-A1 NOVEL HETEROARYL-SUBSTITUTED ARYLAMINOPYRIDINE DERIVATIVES AS MEK INHIBITORS LABORATOIRES SERONO SA (CH) 2007-11-01 — — WO disclosed
Send feedback